|【英語タイトル】Cosmo Pharmaceuticals S.p.A (COPN) - Financial and Strategic SWOT Analysis Review|
Cosmo Pharmaceuticals S.p.A (Cosmo) is a pharmaceutical company that offers therapies. The company develops, produces and markets optimized therapies for treatment of gastrointestinal diseases. Its product pipeline includes Lialda Mezavant Mesavancol; Uceris Cortiment; Rifamycin SV MMX; LMW Heparin MMX; zacol NMX – Nutraceutical; and others. Cosmo develops products based on its Multi Matrix MMX technology. The company’s services include contact manufacturing, evaluates pharmaceutical product stability, assesses manufacturing processes, and sample preparation for clinical trials, among others. Its products find application in the treatment of gastrointestinal tract disorder, inflammatory bowel diseases, colon infections and colon diagnosis, as well as selected topically treated skin disorders. Cosmo is headquartered in Luxembourg.
Cosmo Pharmaceuticals S.p.A Key Recent Developments
Jul 15, 2015: Cosmo Pharmaceuticals and Cassiopea Select DATATRAK Unified Platform for Global Study
This comprehensive SWOT profile of Cosmo Pharmaceuticals S.p.A provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cosmo Pharmaceuticals S.p.A including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Cosmo Pharmaceuticals S.p.A – Key Information
Cosmo Pharmaceuticals S.p.A – Overview
Cosmo Pharmaceuticals S.p.A – Key Employees
Cosmo Pharmaceuticals S.p.A – Key Employee Biographies
Cosmo Pharmaceuticals S.p.A – Key Operational Heads
Cosmo Pharmaceuticals S.p.A – Major Products and Services
Cosmo Pharmaceuticals S.p.A – History
Cosmo Pharmaceuticals S.p.A – Company Statement
Cosmo Pharmaceuticals S.p.A – Locations And Subsidiaries
Cosmo Pharmaceuticals S.p.A – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Cosmo Pharmaceuticals S.p.A – Business Description
Cosmo Pharmaceuticals S.p.A – Corporate Strategy
Cosmo Pharmaceuticals S.p.A – SWOT Analysis
SWOT Analysis – Overview
Cosmo Pharmaceuticals S.p.A – Strengths
Cosmo Pharmaceuticals S.p.A – Weaknesses
Cosmo Pharmaceuticals S.p.A – Opportunities
Cosmo Pharmaceuticals S.p.A – Threats
Cosmo Pharmaceuticals S.p.A – Key Competitors
Section 3 – Company Financial Performance Charts
Cosmo Pharmaceuticals S.p.A – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Cosmo Pharmaceuticals S.p.A, Key Information
Cosmo Pharmaceuticals S.p.A, Key Ratios
Cosmo Pharmaceuticals S.p.A, Share Data
Cosmo Pharmaceuticals S.p.A, Major Products and Services
Cosmo Pharmaceuticals S.p.A, History
Cosmo Pharmaceuticals S.p.A, Key Employees
Cosmo Pharmaceuticals S.p.A, Key Employee Biographies
Cosmo Pharmaceuticals S.p.A, Key Operational Heads
Cosmo Pharmaceuticals S.p.A, Other Locations
Cosmo Pharmaceuticals S.p.A, Subsidiaries
Cosmo Pharmaceuticals S.p.A, Key Manufacturing facilities
Cosmo Pharmaceuticals S.p.A, Key Competitors
Cosmo Pharmaceuticals S.p.A, SWOT Analysis
Cosmo Pharmaceuticals S.p.A, Ratios based on current share price
Cosmo Pharmaceuticals S.p.A, Annual Ratios
Cosmo Pharmaceuticals S.p.A, Interim Ratios
Capital Market Ratios
List of Figures
Cosmo Pharmaceuticals S.p.A, Performance Chart
Cosmo Pharmaceuticals S.p.A, Ratio Charts
|★調査レポート[Cosmo Pharmaceuticals S.p.A (COPN)：企業の財務及び戦略的SWOT分析]
|★調査レポート[Cosmo Pharmaceuticals S.p.A (COPN)：企業の財務及び戦略的SWOT分析]についてメールでお問い合わせ